Sign In
to Vote &
Create Storyboards.
 
Kairos Pharma plans to sell about 1.55 million shares in its initial public offering at $4 per share.
2
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard